RESEARCH TRIANGLE PARK, North Carolina, Sept. 09, 2022 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company digitizing the interface between surgeon and patient to launch a new era of Performance-Guided Surgery™, announced today Saiseikai Shiga Hospital in Ritto, Japan, has entered into an agreement for the rental and use of a Senhance® Surgical System.
“We are delighted to partner with Saiseikai Shiga Hospital, one of Japan’s leading hospitals. While the system will initially be used in the general surgery department, we look forward to helping the hospital expand its Senhance program to other departments and specializations,” said Anthony Fernando, President and CEO of Asensus Surgical. “We continue to drive the increased use of Senhance globally, as surgeons continue to see the value associated with Senhance’s clinical intelligence and digital tools that have broad applicability across all surgical specialties and types of procedures. »
The Senhance Surgical System is the first digital laparoscopic platform of its kind offering surgical assurance through haptic feedback, eye tracking camera control, 3D visualization and 3mm instruments.
Asensus Surgical’s technology platform, Senhance Surgical System, is the first-of-its-kind digital laparoscopic platform that leverages augmented intelligence to deliver unparalleled performance and patient outcomes through machine learning. Senhance goes beyond typical surgical robotic systems, providing surgical assurance through haptic feedback, eye tracking camera control and 3D visualization, and is the first platform to offer 3mm instruments ( the world’s smallest instrument available on a robotic surgical platform).
In surgical procedures, haptic feedback is a highly sought after feature that is only available on the Senhance Surgical System. Haptic feedback gives the surgeon real-time sensory force feedback. Not only does it allow for a more natural feeling of pressure and tension when performing surgical tasks, it provides an unparalleled level of safety that other robotic platforms cannot provide by allowing the surgeon to feel when is in contact with anatomy that can potentially be damaged or injured by the movements of the instrument.
The Senhance Surgical System is powered by the Intelligent Surgical Unit™ (ISU™). The ISU enables real-time surgical image analysis coupled with artificial vision camera control for a surgeon by responding to commands and recognizing certain objects and locations within the surgical field. It allows the surgeon to measure anatomy, place digital tags, enhance the surgical image, and offers augmented intelligence (AI) driven camera control allowing the surgeon to focus on other tasks critical surgeries.
“We are excited to incorporate the unique features of the Senhance system into our surgical offerings. Familiarity with laparoscopy, lower cost per procedure similar to laparoscopy, and clinical intelligence capabilities combined with robotic precision and new features make the platform a wonderful addition to our hospital,” said Dr. M. Masuyama , vice-president, head of the department of surgery. “As we focus on providing the highest level of care to our patients, the Senhance system will allow us to expand our robotic surgery service to help deliver better patient outcomes.”
About Saiseikai Shiga Hospital
Saiseikai Shiga Hospital, a general hospital in Ritto, Japan, is one of the first hospitals of the social welfare organization Saiseikai Imperial Gift Foundation (the Foundation) and commissioned by Emperor Meiji in 1911. For more than 100 years, Saiseikai Shiga Hospital has upheld its founding spirit of “Saisei” or “Saving Lives”, overcoming the challenges posed by ever-changing social and economic circumstances. All the while, Saiseikai Shiga Hospital has continued to carry out activities and programs for the improvement and promotion of national health, medical services and social welfare. Currently, the Foundation is run under the leadership of HIH Patron Prince Akishino as President, President Akito Arima and Chairman of the Board Shigeru Sumitani. The Foundation has an extensive branch network in 40 of Japan’s 47 prefectures, including the only medical ship in Japan operated by the four prefectural branches of Okayama, Hiroshima, Ehime and Kagawa. Visit 53 isolated islands. The Foundation aims to continue to increase its presence as a social welfare organization and a public medical establishment. It employs approximately 64,000 dedicated people engaged in activities related to health, medical and social services. These staff members operate in the Foundation’s 403 facilities and outreach programs. In fiscal year 2021, 20.94 million people were able to benefit from these services.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between surgeon and patient to usher in a new era of performance-driven surgery by unleashing clinical intelligence for surgeons to achieve consistently superior results and a new standard of surgery. This builds on the foundation of digital laparoscopy with the Senhance surgical system powered by Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive, and economic gaps that determine surgical outcomes and value-based healthcare. Learn more about performance-guided surgery and digital laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in USA, EU, Japan, Russia and some other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
Email Alerts: https://ir.asensus.com/email-alerts
This press release includes statements related to Senhance Surgical System and Saiseikai Shiga Hospital launching a program with Senhance System. These and other statements regarding our future plans and objectives constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor of liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties which are often difficult to predict, are beyond our control and which could cause results to differ materially from expectations and include whether the Senhance Surgical System will help develop Saiseikai Shiga Hospital’s robotic surgery department and help deliver better patient outcomes. For a discussion of the risks and uncertainties associated with the Company’s business, please see our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on February 28, 2022 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which are based on our expectations as of the date of this press release and speak only as of the original date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Mark Klausner or Mike Vallie
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/75c93c6c-f513-46f7-a79d-61e73eb45cc6